空間オミックス市場の規模、シェア、成長分析、技術別、製品タイプ別、ワークフロー別、サンプルタイプ別、最終用途別、地域別 - 産業予測、2025～2032年

空間オミックスの世界市場規模は、2023年に3,650億米ドルと評価され、2024年の4,029億6,000万米ドルから2032年には8,892億3,000万米ドルに成長し、予測期間（2025年～2032年）のCAGRは10.4％で成長する見通しです。

空間オミックス市場は、遺伝性疾患の有病率の増加、シークエンシング技術の進歩、革新的研究への投資の高まりによって大きな成長を遂げています。この変革的なアプローチは、遺伝子配列の解読から、細胞タイプやバイオマーカーの空間的な位置関係や相互作用の解析へと焦点をシフトさせています。この分野の主要企業は、約1,800のRNAターゲットを定量化するソリューションを提供しており、分子解析と組織からの空間データを効果的に融合させています。このような空間的ゲノム情報は、疾患の同定と管理に役立つ診断バイオマーカーの開発に不可欠なものとなっています。このように、空間オミックステクノロジーは、組織編成や細胞制御を含む複雑な生物学的メカニズムを理解し、最終的には治療戦略や臨床転帰を向上させるために極めて重要です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ分析

空間オミックス市場規模：技術別

• 市場概要
• 空間トランスクリプトミクス
• 空間ゲノミクス
• 空間プロテオミクス

空間オミックス市場規模：製品別

• 市場概要
• 機器
  • モード別
  • 自動化
  • 半自動
  • マニュアル
  • タイプ別
  • シーケンシングプラットフォーム
  • 国際保健
  • 顕微鏡検査
  • フローサイトメトリー
  • 質量分析
  • その他
• 消耗品
• ソフトウェア
  • バイオインフォマティクスツール
  • イメージングツール
  • ストレージと管理データベース

空間オミックス市場規模：ワークフロー別

• 市場概要
• サンプル調製
• 機器分析
• データ分析

空間オミックス市場規模：サンプルタイプ別

• 市場概要
• FFPE
• 新鮮冷凍

空間オミックス市場規模：最終用途別

• 市場概要
• 学術調査機関およびトランスレーショナルリサーチ機関
• 製薬・バイオテクノロジー企業

空間オミックス市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• 10x Genomics（US）
• Illumina（US）
• Fluidigm Corporation（US）
• Akoya Biosciences（formerly PerkinElmer）（US）
• S2 Genomics, Inc.（US）
• RareCyte, Inc.（US）
• ZEISS Group（Germany）
• Miltenyi Biotec（Germany）
• Bio-Techne Corporation（US）
• Visiopharm（Denmark）
• Indica Labs, Inc.（US）
• Bio-Rad Laboratories, Inc.（US）
• Oxford Nanopore Technologies（UK）
• Takara Bio Inc.（Japan）

結論と推奨事項

Global Spatial Omics Market size was valued at USD 365.0 billion in 2023 and is poised to grow from USD 402.96 billion in 2024 to USD 889.23 billion by 2032, growing at a CAGR of 10.4% during the forecast period (2025-2032).

The spatial omics market is experiencing significant growth, driven by the increasing prevalence of genetic disorders, advancements in sequencing technologies, and heightened investment in innovative research. This transformative approach shifts focus from decoding gene sequences to analyzing the spatial positioning and interactions of cell types and biomarkers. Leading companies in the field are delivering solutions that quantify approximately 1,800 RNA targets, effectively merging molecular analysis with spatial data from tissues. This spatial genomic information is proving essential for developing diagnostic biomarkers that aid in disease identification and management. As such, spatial omics technology is crucial for understanding complex biological mechanisms, including tissue organization and cellular regulation, ultimately enhancing therapeutic strategies and clinical outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Omics Market Segmental Analysis

Global Spatial Omics Market is segmented by Technology, Product, Workflow, Sample Type, End-use and region. Based on Technology, the market is segmented into Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics. Based on Product, the market is segmented into Instruments, Consumables and Software. Based on Workflow, the market is segmented into Sample Preparation, Instrumental Analysis and Data Analysis. Based on Sample Type, the market is segmented into FFPE and Fresh Frozen. Based on End-use, the market is segmented into Academic & Translational Research Institutes and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spatial Omics Market

The Global Spatial Omics market is poised for significant growth, driven primarily by the increasing prevalence of genetic disorders that tend to be hereditary. As uncertainties surrounding health conditions rise, there is a growing desire among individuals to understand and detect these disorders through advanced omics technologies. This demand underscores the importance of spatial omics tools, which facilitate the identification and analysis of genetic anomalies within various biological samples. Consequently, the need for these innovative diagnostics and research solutions is propelling the expansion of the spatial omics market, making it a critical sector in addressing genetic health challenges.

Restraints in the Global Spatial Omics Market

The Global Spatial Omics market faces significant restraints that may impede its growth prospects. One major challenge is the shortage of skilled professionals with expertise in this emerging research domain, which is expected to limit advancements and further developments. Since Spatial Omics is still a relatively novel field, there is a lack of widespread acceptance and understanding, leading to cautious adoption among researchers and institutions. This limited recognition can stifle innovation and investment, ultimately hindering the overall expansion of the market during the forecast period. Addressing these issues will be crucial to unlocking the full potential of Spatial Omics.

Market Trends of the Global Spatial Omics Market

The Global Spatial Omics market is currently witnessing a significant uptick as the demand for advanced diagnostic tools grows, particularly in oncology. The innovative spatial omics techniques, which effectively elucidate the complex mechanisms governing cell interactions at tumor boundaries, are gaining traction due to their potential to enhance early malignancy detection. This trend is fueled by increasing investments in research and development, coupled with rising prevalence of cancers worldwide. Furthermore, the integration of spatial omics with existing genomic and transcriptomic technologies promises breakthroughs in personalized medicine, paving the way for a robust market expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Spatial Omics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Spatial Transcriptomics
• Spatial Genomics
• Spatial Proteomics

Global Spatial Omics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
  • By Mode
  • Automated
  • Semi-automated
  • Manual
  • By Type
  • Sequencing Platforms
  • IHC
  • Microscopy
  • Flow Cytometry
  • Mass Spectrometry
  • Others
• Consumables
• Software
  • Bioinformatics Tools
  • Imaging Tools
  • Storage & Management Databases

Global Spatial Omics Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sample Preparation
• Instrumental Analysis
• Data Analysis

Global Spatial Omics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• FFPE
• Fresh Frozen

Global Spatial Omics Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Academic & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies

Global Spatial Omics Market Size & CAGR (2025-2032)

• North America (Technology, Product, Workflow, Sample Type, End-use)
  • US
  • Canada
• Europe (Technology, Product, Workflow, Sample Type, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Workflow, Sample Type, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Workflow, Sample Type, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Workflow, Sample Type, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 10x Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akoya Biosciences (formerly PerkinElmer) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S2 Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RareCyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Visiopharm (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations